|
gptkbp:instanceOf
|
gptkb:Bacteria
|
|
gptkbp:antibioticResistance
|
increasing
|
|
gptkbp:antibioticTreatment
|
gptkb:azithromycin
gptkb:chloramphenicol
gptkb:ampicillin
gptkb:ceftriaxone
gptkb:trimethoprim-sulfamethoxazole
ciprofloxacin
|
|
gptkbp:antigen
|
gptkb:H_antigen
gptkb:O_antigen
gptkb:Vi_antigen
|
|
gptkbp:biosafetyLevel
|
gptkb:BSL-2
|
|
gptkbp:catalaseTest
|
positive
|
|
gptkbp:cause
|
typhoid fever
|
|
gptkbp:containsSerotype
|
gptkb:Typhi
|
|
gptkbp:discoveredBy
|
gptkb:Karl_Joseph_Eberth
|
|
gptkbp:diseaseReservoir
|
human gallbladder
|
|
gptkbp:domain
|
gptkb:Bacteria
|
|
gptkbp:family
|
gptkb:Enterobacteriaceae
|
|
gptkbp:firstDescribed
|
1880
|
|
gptkbp:flagella
|
peritrichous
|
|
gptkbp:genus
|
gptkb:Salmonella
|
|
gptkbp:gramReaction
|
negative
|
|
gptkbp:gramStain
|
Gram-negative
|
|
gptkbp:habitat
|
human intestine
|
|
gptkbp:hostedBy
|
humans
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Salmonella typhi
|
|
gptkbp:incubationPeriod
|
6-30 days
|
|
gptkbp:motility
|
motile
|
|
gptkbp:oxidaseTest
|
negative
|
|
gptkbp:oxygenRequirement
|
facultative anaerobe
|
|
gptkbp:pathogenicTo
|
yes
|
|
gptkbp:publicHealthConcern
|
yes
|
|
gptkbp:relatedTo
|
gptkb:Salmonella_paratyphi
|
|
gptkbp:shape
|
rod-shaped
|
|
gptkbp:sporeFormation
|
non-spore-forming
|
|
gptkbp:symptom
|
fever
abdominal pain
constipation
headache
rash
|
|
gptkbp:taxonRank
|
gptkb:species
|
|
gptkbp:transmission
|
fecal-oral route
|
|
gptkbp:treatment
|
antibiotics
|
|
gptkbp:typeStrain
|
gptkb:Ty2
|
|
gptkbp:vaccineAvailable
|
yes
|
|
gptkbp:vaccineType
|
injectable polysaccharide
oral live attenuated
|
|
gptkbp:WHOClassification
|
Group B infectious agent
|
|
gptkbp:bfsParent
|
gptkb:The_Typhoid_Croyd_Outbreak
gptkb:Chick-Martin_test
|
|
gptkbp:bfsLayer
|
7
|